AGIOS PHARMACEUTICALS, INC. Income Tax Expense (Benefit) in USD from 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Agios Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2011 to Q3 2025.
  • Agios Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2025 was $0.000, a 100% decline year-over-year.
  • Agios Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2024 was $44.2M.
  • Agios Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Agios Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)

AGIOS PHARMACEUTICALS, INC. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $0 -$53.1M -100% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-30
Q3 2024 $53.1M +$53.1M Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-30
Q3 2023 $0 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q4 2022 $0 $0 Oct 1, 2022 Dec 31, 2022 10-K 2025-02-13
Q3 2022 $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q3 2021 $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $0 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $0 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q1 2017 $0 $0 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $0 $0 $0 Oct 1, 2016 Dec 31, 2016 10-K 2019-02-14
Q3 2016 $0 $0 $0 Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $0 $0 $0 Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $0 $0 $0 Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $0 $0 -$22K -100% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-14
Q3 2015 $22K $0 +$448K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$426K $0 $0 Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-07
Q1 2015 -$426K $0 $0 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$426K $22K -$147K -87% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-16
Q3 2014 -$279K -$448K -$569K -470% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $290K $0 -$99K -100% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $389K $0 -$190K -100% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $579K $169K Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 $121K +$573K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $99K +$687K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $190K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q3 2012 -$452K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 -$588K Apr 1, 2012 Jun 30, 2012 10-Q 2013-09-05

AGIOS PHARMACEUTICALS, INC. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $44.2M +$44.2M Jan 1, 2024 Dec 31, 2024 10-K 2025-02-13
2023 $0 $0 Jan 1, 2023 Dec 31, 2023 10-K 2025-02-13
2022 $0 Jan 1, 2022 Dec 31, 2022 10-K 2025-02-13
2019 $0 $0 Jan 1, 2019 Dec 31, 2019 10-K 2020-02-19
2018 $0 $0 Jan 1, 2018 Dec 31, 2018 10-K 2020-02-19
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2020-02-19
2016 $0 $0 Jan 1, 2016 Dec 31, 2016 10-K 2019-02-14
2015 $0 +$426K Jan 1, 2015 Dec 31, 2015 10-K 2018-02-14
2014 -$426K -$1.01M -174% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-16
2013 $579K +$3.4M Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
2012 -$2.82M -$10M -139% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-24
2011 $7.21M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.